This effect is seen in glioma, with ADAR3 expression dropping as tumor stage progresses, a pattern found both in the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA; [25]). Here, ADARB2 is linked to central nervous system cancer.